BORTEZOMIB-BASED THERAPY IN FRAIL MULTIPLE MYELOMA PATIENTS

被引：0
|
作者：
Antonioli, E.
Staderini, M.
Nozzoli, C.
Bacchiarri, F.
Barone, F.
Grieco, P.
Coltro, G.
Guarrera, A.
Messeri, M.
Bosi, A.
机构：
[1] Azienda Osped Univ Careggi, SODC Ematol, Careggi, Italy
[2] Azienda Osped Univ Careggi, SOD Terapie Cellulari & Med Trasfus, Careggi, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P202
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [31] Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
    Wei, Min
    Guo, Honggang
    Liu, Siwei
    Xu, Fangfang
    Zhang, Yin
    Shi, Jie
    Xu, Zhiwei
    Chen, Yuqing
    [J]. MEDICINE, 2021, 100 (41) : E27521
  • [32] Bortezomib-based regimens for primary multiple myeloma patients in China: from 2006 to 2018
    Cai, Zhen
    He, Jingsong
    He, Donghua
    Han, Xiaoyan
    Zheng, Gaofeng
    Zhao, Yi
    Yang, Yang
    Wu, Wenjun
    Huang, He
    Fu, Jiaping
    Shou, Lihong
    Kong, Hongwei
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E202 - E202
  • [33] Bortezomib-based regimens for primary multiple myeloma patients in China: from 2006 to 2018
    He, J.
    He, D.
    Han, X.
    Zheng, G.
    Wei, G.
    Zhao, Y.
    Yang, Y.
    Wu, W.
    Huang, H.
    Cai, Z.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1904 - 1904
  • [34] Voriconazole Increase the Risk of PN in Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy
    Xu, Yan
    Deng, Shuhui
    An, Gang
    Li, Zengjun
    Qin, Xiaoqi
    Sui, Weiwei
    Feng, Xiaoyan
    Zou, Dehui
    Qiu, Lugui
    [J]. BLOOD, 2015, 126 (23)
  • [35] Effective Bortezomib-Based Therapy for IgM Myeloma in 2 Patients with Unique Cytogenetic Features
    Willenbacher, E.
    Erdel, M.
    Strasser, U.
    Gastl, G.
    Schmidt, S.
    Willenbacher, W.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S51 - S52
  • [36] Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice
    Terpos, Evangelos
    Katodritou, Eirini
    de la Rubia, Javier
    Hungria, Vania
    Hulin, Cyrille
    Roussou, Maria
    Delforge, Michel
    Bries, Greet
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Belch, Andrew
    Ahlberg, Lucia
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Spencer, Mike
    Potamianou, Anna
    van de Velde, Helgi
    Dimopoulos, Meletios A.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (04) : 556 - 565
  • [37] Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Pezzi, Annalisa
    Rocchi, Serena
    Cavo, Michele
    [J]. HAEMATOLOGICA, 2014, 99 (11)
  • [38] ANAPLASTIC MULTIPLE MYELOMA WITH COMPLETE RESPONSE TO BORTEZOMIB-BASED TRIPLET REGIMEN
    Ellithi, Moataz
    Abdullah, Hafez Mohammad
    Omar, Mohamed
    [J]. ANTICANCER RESEARCH, 2019, 39 (10) : 5848 - 5849
  • [39] Bortezomib-Based Therapy, without Stem Cell Transplantation, for Newly Diagnosed Multiple Myeloma Patients with t(4;14)
    Reece, Donna E.
    Rodriguez, Giovanni Piza
    Belch, Andrew
    Szwajcer, David
    Pantoja, Mariela
    Kovacs, Michael
    Shustik, Chaim
    Bahlis, Nizar J.
    White, Darrell J.
    Chen, Christine
    Kukreti, Vishal
    Anglin, Peter
    Stewart, A. Keith
    Trudel, Suzanne
    [J]. BLOOD, 2009, 114 (22) : 1485 - 1486
  • [40] High Cut-off Hemodialysis Combined with Bortezomib-Based Therapy in Multiple Myeloma Patients with Severe Renal Impairment
    Baertsch, Marc-A.
    Raab, Marc S.
    Beimler, Joerg
    Meissner, Julia
    Schmier, Johann
    Goldschmidt, Hartmut
    Hillengass, Jens
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E120 - E120
12345